These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Significance of the changes in pulmonary diffusing capacity and its components in evaluating initial respiratory disorders in chronic non-obstructive bronchitis]. Laskin GM; Kuznetsova VK; Zil'ber NA Ter Arkh; 1981; 53(3):91-6. PubMed ID: 7256621 [No Abstract] [Full Text] [Related]
24. [Behavior of diffusion capacity for carbon monoxide in 2 groups of subjects with pulmonary tuberculosis and chronic obstructive bronchopathy]. Lo Coco A G Ital Mal Torace; 1970; 24(1):27-30. PubMed ID: 5514979 [No Abstract] [Full Text] [Related]
25. [Influence of treatment on clinical state and ventilatory function in patients with chronic bronchitis]. Navrátil M Vnitr Lek; 1971 Apr; 17(4):352-60. PubMed ID: 5581192 [No Abstract] [Full Text] [Related]
31. [Clinical value of determination of pulmonary diffusing capacity in breath holding and normal state in chronic obstructive bronchitis]. Kanaev NN; Laskin GM Ter Arkh; 1980; 52(3):54-7. PubMed ID: 7385040 [No Abstract] [Full Text] [Related]
32. Clinical significance of the ratio between breath-holding and steady-state diffusing capacity in patients with chronic bronchitis and diffuse lung fibrosis. Kanaev NN; Laskin GM Bull Eur Physiopathol Respir; 1980; 16(4):511-9. PubMed ID: 6773609 [No Abstract] [Full Text] [Related]
33. [The significance of an alpine climate in the combined treatment of occupational diseases]. Tolmach DV; Bondarenko GA; Soboleva NP; Denisenko AF; Ignatova OA Vrach Delo; 1989 Oct; (10):109-11. PubMed ID: 2617967 [TBL] [Abstract][Full Text] [Related]
34. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis]. Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058 [TBL] [Abstract][Full Text] [Related]